Boundless Bio (BOLD) Research & Development (2023 - 2026)
Boundless Bio's Research & Development came in at $13.97 million for Q2 2026, up 14.4% from $12.22 million a year earlier and up 43.5% from the prior quarter.
Powered by 
Analysis
Boundless Bio (BOLD) Research & Development (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Boundless Bio reported Research & Development of $44.2 million, down 14.6% year-over-year; for FY2025, it came in at $44.85 million, down 18.9% from FY2024.
- Going back by year, Research & Development was $55.27 million in FY2024 (+29.6%) and $42.64 million in FY2023.
- The Q2 2026 figure represents the highest quarterly Research & Development since Q3 2024.
- Year-over-year, Research & Development increased in three of the last eight quarters, with an average decline of 4.0%.
- The fastest year-over-year change in Research & Development over five years came in Q1 2024 (growth of 38.2%), and the weakest in Q4 2025 (a decline of 26.3%).
- Business Quant data shows BOLD's Research & Development at $9.73 million (Q1 2026), $9.82 million (Q4 2025) and $10.67 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Boundless Bio | 58.66 Mn | 58.66 Mn | - | 13.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.97 Mn |
| Mar 31, 2026 | 9.73 Mn |
| Dec 31, 2025 | 9.82 Mn |
| Sep 30, 2025 | 10.67 Mn |
| Jun 30, 2025 | 12.22 Mn |
| Mar 31, 2025 | 12.14 Mn |
| Dec 31, 2024 | 13.31 Mn |
| Sep 30, 2024 | 14.09 Mn |
| Jun 30, 2024 | 14.74 Mn |
| Mar 31, 2024 | 13.13 Mn |
| Dec 31, 2023 | 10.41 Mn |
| Sep 30, 2023 | 11.65 Mn |
| Jun 30, 2023 | 11.08 Mn |
| Mar 31, 2023 | 9.50 Mn |
API Access
Boundless Bio Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BOLD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BOLD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BOLD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();